文献速递肝病

低皮下脂肪量与肝硬化女性患者较高死亡率相关

Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis.
PubMed 文献 · J Hepatol · 2018-04-28

该研究纳入677例接受肝移植评估的肝硬化患者,通过第3腰椎CT量化骨骼肌指数、内脏脂肪指数和皮下脂肪指数。性别分层多变量分析显示,女性低皮下脂肪指数与较高死亡风险独立相关,男性低骨骼肌指数为死亡预测因素。

要点

  • 女性肝硬化患者低皮下脂肪指数(<60 cm2/m2)与较高死亡风险相关(HR 2.06)。
  • 男性肝硬化患者低骨骼肌指数为死亡的独立预测因素(HR 0.98)。
  • 皮下脂肪而非内脏脂肪与女性肝硬化患者预后相关。

核心结论

  • 较低皮下脂肪指数与肝硬化女性患者较高死亡率相关。
  • 皮下脂肪具有有利的代谢特征,低皮下脂肪指数可能反映主要能量储备耗竭,导致不良临床结局。

研究设计与样本

  • 研究纳入677例接受肝移植评估的肝硬化患者,使用第3腰椎CT图像量化身体组成指数(cm2/m2):内脏脂肪指数、皮下脂肪指数(SATI)和骨骼肌指数(SMI)。
  • 采用Cox比例风险和竞争风险分析危害模型评估死亡率与身体组成的关联。

主要发现

  • 多数患者为男性(67%),平均年龄57±7岁,MELD评分14±8,平均体重指数27±6 kg/m2。
  • 尽管性别间体重指数相似,男性骨骼肌指数较高(53±12 vs. 45±9 cm2/m2),而女性皮下脂肪指数较高(67±52 vs. 48±37 cm2/m2)(p<0.001)。
  • 性别分层多变量分析中,调整MELD评分和其他混杂变量后,女性皮下脂肪指数(HR 0.99;95%CI 0.98-1.00;p=0.01)和男性骨骼肌指数(HR 0.98;95%CI 0.96-1.00;p=0.02)为死亡的显著预测因素。
  • 女性低皮下脂肪指数(<60 cm2/m2)患者死亡风险较高(HR 2.06;95%CI 1.08-3.91;p=0.03)。
  • 在等待肝移植的女性患者中,调整MELD和其他混杂因素后,低皮下脂肪指数也是死亡的独立预测因素(亚分布HR 2.80;95%CI 1.28-6.12;p=0.01)。

关键数值与推荐

  • 女性低皮下脂肪指数定义为<60 cm2/m2,与较高死亡风险相关(HR 2.06;95%CI 1.08-3.91;p=0.03)。
  • 女性皮下脂肪指数每单位与死亡风险相关(HR 0.99;95%CI 0.98-1.00;p=0.01)。
  • 男性骨骼肌指数每单位与死亡风险相关(HR 0.98;95%CI 0.96-1.00;p=0.02)。
  • 等待肝移植女性中低皮下脂肪指数与死亡风险相关(亚分布HR 2.80;95%CI 1.28-6.12;p=0.01)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Two major body compartments, skeletal muscle and adipose tissue, exhibit independent functions. We aimed to explore the prognostic significance of skeletal muscle, visceral and subcutaneous adipose tissue, according to sex, in patients with cirrhosis assessed for liver transplantation (LT). METHODS: CT images taken at the 3rd lumbar vertebra from 677 patients were quantified for three body composition indexes (cm2/m2), visceral adipose tissue index, subcutaneous adipose tissue index (SATI), and skeletal muscle index (SMI). Cox proportional and competing-risk analysis hazard models were conducted to assess associations between mortality and body composition. RESULTS: The majority of patients were male (67%) with a mean age of 57 ± 7 years, model for end-stage liver disease (MELD) score of 14 ± 8 and mean body mass index of 27 ± 6 kg/m2. Despite similar body mass index between the sexes, male patients had greater SMI (53 ± 12 vs. 45 ± 9 cm2/m2), whereas SATI (67 ± 52 vs. 48 ± 37 cm2/m2) was higher in females (p <0.001 for each). In sex stratified multivariate analyses after adjustment for MELD score and other confounding variables, SATI in females (hazard ratio [HR] 0.99; 95% CI 0.98-1.00; p = 0.01) and SMI in males (HR 0.98; 95% CI 0.96-1.00; p = 0.02) were significant predictors of mortality. Female patients with low SATI (<60 cm2/m2) had a higher risk of mortality (HR 2.06; 95% CI 1.08-3.91; p = 0.03). Using competitive risk analysis in female patients listed for LT, low SATI was also an independent predictor of mortality (subdistribution HR 2.80; 95% CI 1.28-6.12; p = 0.01) after adjusting for MELD, and other confounding factors. CONCLUSIONS: A lower SATI is associated with higher mortality in female patients with cirrhosis. Subcutaneous adipose tissue has a favorable metabolic profile - low SATI may reflect depletion of this major energy reservoir, leading to poor clinical outcomes. LAY SUMMARY: We looked at the importance of two of the main body compartments, skeletal muscle and adipose tissue (fat) on the prognosis of males and females with end-stage liver disease. Lower amounts of subcutaneous fat but not visceral fat (around internal organs), are associated with higher mortality in female patients with end-stage liver disease. However, low skeletal muscle predicts mortality in male patients with end-stage liver disease.

来源:J Hepatol,查看原文。版权归原作者所有。

引用

  1. Ebadi M, Tandon P, Moctezuma-Velazquez C, et al. Low subcutaneous adiposity associates with higher mortality in female patients with cirrhosis. J Hepatol. 2018. PMID: 29709682. doi:10.1016/j.jhep.2018.04.015

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。